Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology.

Institute of Hygiene, University Münster, Münster, Germany.
PLoS ONE (Impact Factor: 3.53). 07/2011; 6(7):e22751. DOI: 10.1371/journal.pone.0022751
Source: PubMed

ABSTRACT An ongoing outbreak of exceptionally virulent Shiga toxin (Stx)-producing Escherichia coli O104:H4 centered in Germany, has caused over 830 cases of hemolytic uremic syndrome (HUS) and 46 deaths since May 2011. Serotype O104:H4, which has not been detected in animals, has rarely been associated with HUS in the past. To prospectively elucidate the unique characteristics of this strain in the early stages of this outbreak, we applied whole genome sequencing on the Life Technologies Ion Torrent PGM™ sequencer and Optical Mapping to characterize one outbreak isolate (LB226692) and a historic O104:H4 HUS isolate from 2001 (01-09591). Reference guided draft assemblies of both strains were completed with the newly introduced PGM™ within 62 hours. The HUS-associated strains both carried genes typically found in two types of pathogenic E. coli, enteroaggregative E. coli (EAEC) and enterohemorrhagic E. coli (EHEC). Phylogenetic analyses of 1,144 core E. coli genes indicate that the HUS-causing O104:H4 strains and the previously published sequence of the EAEC strain 55989 show a close relationship but are only distantly related to common EHEC serotypes. Though closely related, the outbreak strain differs from the 2001 strain in plasmid content and fimbrial genes. We propose a model in which EAEC 55989 and EHEC O104:H4 strains evolved from a common EHEC O104:H4 progenitor, and suggest that by stepwise gain and loss of chromosomal and plasmid-encoded virulence factors, a highly pathogenic hybrid of EAEC and EHEC emerged as the current outbreak clone. In conclusion, rapid next-generation technologies facilitated prospective whole genome characterization in the early stages of an outbreak.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Structured nucleic acids are recognized as a molecular switch by inducing conformational displacement upon target recognition. The appearance of oligonucleotide aptamers that can bind to a wide variety of target molecules with high sensitivity and selectivity has expanded the possibility of the nano-switch in analytical applications. Molecularly engineered oligonucleotide aptamers are designed to induce intra- or inter- molecular displacement upon target binding. Essentially, increasingly detailed structural designs are highlighting the utility of oligonucleotide aptamers for diagnostic systems. The primary and secondary structures of nucleic acid aptamers are responsible for structural displacement upon target binding. Recent developments on structured aptamer for biosensor application are reviewed here. In particular, we revealed that a hairpin-structured single-stranded aptamer enabled to capture a target molecule only when the aptamer transformed into the open-loop conformation by temperature-induced self-dissociation. The hairpin aptamer as a thermo-responsive ligand has much generality for its use as "smart" molecular switches.
    Nanotechnology, Volume 10 Nanosensing, Edited by N. K. Navani, S. Sinha, and J. N. Govil, 01/2013: chapter 3: pages 37-58; Studium Press LLC., ISBN: 1-62699-010-7
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recent advances in DNA sequencing technologies have the potential to transform the field of clinical and public health microbiology, and in the last few years numerous case studies have demonstrated successful applications in this context. Among other considerations, a lack of user-friendly data analysis and interpretation tools has been frequently cited as a major barrier to routine use of these techniques. Here we consider the requirements of microbiology laboratories for the analysis, clinical interpretation and management of bacterial whole-genome sequence (WGS) data. Then we discuss relevant, existing WGS analysis tools. We highlight many essential and useful features that are represented among existing tools, but find that no single tool fulfils all of the necessary requirements. We conclude that to fully realise the potential of WGS analyses for clinical and public health microbiology laboratories of all scales, we will need to develop tools specifically with the needs of these laboratories in mind.
    Pathogens (Basel, Switzerland). 06/2014; 3(2):437-458.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The availability of genome sequences obtained using next-generation sequencing (NGS) has revolutionized the field of infectious diseases. Indeed, more than 38,000 bacterial and 5,000 viral genomes have been sequenced to date, including representatives of all significant human pathogens. These tremendous amounts of data have not only enabled advances in fundamental biology, helping to understand the pathogenesis of microorganisms and their genomic evolution, but have also had implications for clinical microbiology. Here, we first review the current achievements of genomics in the development of improved diagnostic tools, including those that are now available in the clinic, such as the design of PCR assays for the detection of microbial pathogens, virulence factors or antibiotic-resistance determinants, or the design of optimized culture media for 'unculturable' pathogens. We then review the applications of genomics to the investigation of outbreaks, either through the design of genotyping assays or the direct sequencing of the causative strains. Finally, we discuss how genomics might change clinical microbiology in the future.
    Genome Medicine 01/2014; 6(11):114. · 4.94 Impact Factor

Full-text (2 Sources)

Available from
May 16, 2014